NEJM:甲状腺癌的过度诊断尤其明显

2015-02-23 小卡 健康之家

随着检查手段的进步,许多癌症都能够在早期就被查出,这是为了挽救患者的生命,可有时候事实并非如此。一些对健康没有影响的低危癌症也被检出,不治疗让人感到不放心,可治疗却会对身体造成不必要的负担。 甲状腺癌的过度诊断 美国达特茅斯学院盖泽尔医学院的Welch教授发现,在1973~2002年间,被诊断为甲状腺癌的人增加了一倍,然而死于甲状腺癌的人数却没有什么变化。一般说来,如果癌症的早


随着检查手段的进步,许多癌症都能够在早期就被查出,这是为了挽救患者的生命,可有时候事实并非如此。一些对健康没有影响的低危癌症也被检出,不治疗让人感到不放心,可治疗却会对身体造成不必要的负担。

甲状腺癌的过度诊断

美国达特茅斯学院盖泽尔医学院的Welch教授发现,在1973~2002年间,被诊断为甲状腺癌的人增加了一倍,然而死于甲状腺癌的人数却没有什么变化。一般说来,如果癌症的早期诊断和治疗有效果的话,那么死于癌症的人数应该有所减少。如果死亡人数完全没有变化,说明一些诊断和治疗可能是没有必要的,一些患者即使没有接受治疗也不会死于甲状腺癌。2014年美国最新的数据分析也发现,从1975到2009年,确诊为甲状腺癌的人数增加了3倍,可是死亡率一直维持在每10万人0.5人。新增的甲状腺患者大多是患的甲状腺乳头状癌,这是一种常见的甲状腺癌,不过生长慢、恶性度也最轻,一般肿瘤大小都不超过2厘米,其中一些患者可能属于被过度诊断了。研究还发现,女性更容易受到过度诊断。因为新增的甲状腺癌女患者比男患者要多出4倍,不过在尸体解剖的时候却更容易发现男性的甲状腺癌。

手术的弊大于利

甲状腺癌的治疗一般会切除一些或者所有的甲状腺。然而,患者的喉咙和神经也有可能在手术过程中被损害,从而导致声音受到影响。另外,甲状旁腺也有可能受到影响,它控制着身体中的钙水平,所以许多甲状腺癌患者都会在术后缺钙。一旦甲状腺被切除,患者就需要终生服药来代替甲状腺的功能。和任何治疗手段一样,甲状腺癌的治疗也存在一些负面作用,问题的关键是,对于一些患者来说,治疗带来的好处真的更大吗?

先观察再活检

光靠触诊很难检查甲状腺的小肿块,医生一般会让患者接受超声波检查。如果超声波检查发现了甲状腺结节,那么下一步医生会建议患者接受甲状腺细针穿刺活检(FNB)。然而,由于患者脖子的生理构造、进行穿刺检查的医生的技术、辨别细胞的细胞病理学家的经验等都有可能造成活检结果的不确定性。可能对于患者来讲,最为实际的标准是,甲状腺结节会不会继续长大。对于肺癌,医生主要是观察肺部疑似癌症的损伤会不会持续长大,如果会,医生才做穿刺活检。也许肺癌的这种经验也可以运用到甲状腺癌上。

由于一些甲状腺癌检查在没有挽救性命的情况下,导致了“多余”的诊断和手术,所以Welch教授疑惑,过早的诊断真的应该继续进行吗?当然,当脖子出现了很明显的肿块时,患者应该立即去看医生。如果只是发现了比较可疑的甲状腺结节,那是否可以先“观察等待”,或者“密切监视”结节会不会变大。这种做法被称作“期待治疗”(expectant management)。

借鉴前列腺癌的做法

前列腺癌是使用期待治疗较多的癌症。像甲状腺乳头状癌一样,前列腺癌也生长缓慢,一些老年患者或者有其他严重疾病的患者可能根本就不需要接受前列腺癌的治疗。但医生会使用PSA血检、直肠检查和超声波检查,定期(每3~6个月)检测患者的前列腺癌生长情况。当癌症变得更加有危险性时,医生才会考虑活检。如果患者的某一次定期检查出现了变化,医生便会跟他讨论治疗方案。这么做可以避免一些癌症并不凶险的患者接受过度治疗。

至于对哪些患者进行期待治疗,前列腺癌医生会参照格里森评分(gleason grade)。一般格里森评分低的前列腺癌患者,都没有明显症状,癌症也生长缓慢,可以先观察,而对于格里森评分高的前列腺癌患者,癌症则很有可能迅速扩散,期待治疗就不再适用了。

不手术并非放弃

日本已有研究显示,对甲状腺微小乳头状癌(甲状腺乳头状癌的一种亚型)进行期待治疗是安全的。美国纽约的Sloan-Kettering纪念癌症中心也开始了关于甲状腺乳头状癌的预期治疗的临床试验。74位甲状腺内肿瘤直径小于1.5厘米的患者接受了期待治疗,在为期1年的随访调查后,95%的患者的病情在严密的监测下并没有发展。有1位患者因为肿瘤长大而接受了手术,还有三位患者尽管病情稳定,仍然因为害怕癌症扩散选择了接受手术。从目前的结果来看,对于一些患者来说,期待治疗的确可以替代一旦发现癌症就立即切除的标准做法,关键是患者是否能够扭转“不手术就是放弃”的观念。也许,不论是医生还是患者都应该慢慢改变对癌症的看法,在癌症对健康并不会造成太大影响和危及生命的情况下,带癌生存不仅不会缩短寿命,还能够减少治疗和手术对身体造成的伤害。在过度诊断无法改变的时候,对于治疗就必须更加谨慎。

其它肿瘤也有一些的近似

乳腺癌早期诊断的优势越来越明显,大量乳腺癌患者在早期被成功诊断,但是近期一项研究表明,最近10年来乳腺癌的死亡人数并没有减少。早期诊断有助于发现一些早期肿瘤,但也可能由于过度诊断,使某些患者心理负担加重,加速肿瘤的复发或致死的风险。

国际上一大批学者开始反思早期诊断的实际价值。

原始出处:

Ahn HS, Kim HJ, Welch HG.Korea's thyroid-cancer "epidemic"--screening and overdiagnosis. N Engl J Med. 2014 Nov 6;371(19):1765-7.

Davies L, Welch HG.Thyroid cancer survival in the United States: observational data from 1973 to 2005. Arch Otolaryngol Head Neck Surg. 2010 May;136(5):440-4.

Welch HG, Black WC.Overdiagnosis in cancer. J Natl Cancer Inst. 2010 May 5;102(9):605-13

Sopik V, Narod SA.Overdiagnosis in breast cancer chemoprevention trials. Curr Oncol. 2015 Feb;22(1):e6-e10.

Marcus PM, Prorok PC, Miller AB, DeVoto EJ, Kramer BS.Conceptualizing overdiagnosis in cancer screening. J Natl Cancer Inst. 2015 Feb 6;107(4). pii: djv014.

Pandeya N, McLeod DS, Balasubramaniam K, Baade PD, Youl PH, Bain CJ, Allison R, Jordan SJ.Increasing thyroid cancer incidence in Queensland, Australia 1982-2008 - true increase oroverdiagnosis? Clin Endocrinol (Oxf). 2015 Jan 19. doi: 10.1111/cen.12724

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (13)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=146788, encodeId=223e146e8852, content=直到身边亲人被过度了才体验深刻,病人观念也没跟上,医生也很少考虑全切后的终生治疗及并发症各种的麻烦, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRtNT7AWKboIfjpeY6Nw6lNxAc4w1aibutHSqCJ2c3AbwfqpRia4IrnzU2mK3Ojx2Har8AUUyhC0kl7/0, createdBy=ecc31722157, createdName=1decafd9m46(暂无匿称), createdTime=Wed Oct 12 13:29:18 CST 2016, time=2016-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60775, encodeId=1e4460e750c, content=不错,赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:53:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60776, encodeId=8b1d60e765c, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:53:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60777, encodeId=dbeb60e7776, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:53:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60778, encodeId=a4de60e78d7, content=值得进一步关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:53:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24350, encodeId=75d42435071, content=1,原文出处?还是小编自己从这几个地方总结而来?2,纳入74例,样本量较少。关键是随访时间较短,对于微小癌就更短。。因为其本身发展缓慢。。。后续仍需长期进行随访。3,如前面同仁所说,关键还是能找出预测该瘤子侵袭性的因素,这将很有意义!, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160515/IMG57380B859AD1F1019.jpg, createdBy=2c5c1621956, createdName=jasonuclear, createdTime=Thu May 21 10:03:00 CST 2015, time=2015-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23705, encodeId=4a8323e0553, content=很不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sat May 16 19:31:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17618, encodeId=fc3f1e61814, content=看着比较靠谱, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ecc41613739, createdName=momoqiantan, createdTime=Thu Mar 05 10:21:00 CST 2015, time=2015-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16995, encodeId=5a5f16995dc, content=解决这个问题的前提是如何鉴别侵袭性甲状腺癌!, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=106.37.162.**, createdTime=Wed Feb 25 17:08:00 CST 2015, time=2015-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16920, encodeId=9f6b1692007, content=不错啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3yz0JbjHQ7nicJU7lHMOu0Itf3Zv3VBzEvK3k4AFPBXhiaxIRNGVI33GicoRXQEjkaasjdlWKwZuwcyhDP9Jibqt5ct/0, createdBy=f1281613275, createdName=zhouanxiu, createdTime=Tue Feb 24 15:19:00 CST 2015, time=2015-02-24, status=1, ipAttribution=)]
    2016-10-12 1decafd9m46(暂无匿称)

    直到身边亲人被过度了才体验深刻,病人观念也没跟上,医生也很少考虑全切后的终生治疗及并发症各种的麻烦

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=146788, encodeId=223e146e8852, content=直到身边亲人被过度了才体验深刻,病人观念也没跟上,医生也很少考虑全切后的终生治疗及并发症各种的麻烦, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRtNT7AWKboIfjpeY6Nw6lNxAc4w1aibutHSqCJ2c3AbwfqpRia4IrnzU2mK3Ojx2Har8AUUyhC0kl7/0, createdBy=ecc31722157, createdName=1decafd9m46(暂无匿称), createdTime=Wed Oct 12 13:29:18 CST 2016, time=2016-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60775, encodeId=1e4460e750c, content=不错,赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:53:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60776, encodeId=8b1d60e765c, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:53:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60777, encodeId=dbeb60e7776, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:53:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60778, encodeId=a4de60e78d7, content=值得进一步关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:53:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24350, encodeId=75d42435071, content=1,原文出处?还是小编自己从这几个地方总结而来?2,纳入74例,样本量较少。关键是随访时间较短,对于微小癌就更短。。因为其本身发展缓慢。。。后续仍需长期进行随访。3,如前面同仁所说,关键还是能找出预测该瘤子侵袭性的因素,这将很有意义!, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160515/IMG57380B859AD1F1019.jpg, createdBy=2c5c1621956, createdName=jasonuclear, createdTime=Thu May 21 10:03:00 CST 2015, time=2015-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23705, encodeId=4a8323e0553, content=很不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sat May 16 19:31:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17618, encodeId=fc3f1e61814, content=看着比较靠谱, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ecc41613739, createdName=momoqiantan, createdTime=Thu Mar 05 10:21:00 CST 2015, time=2015-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16995, encodeId=5a5f16995dc, content=解决这个问题的前提是如何鉴别侵袭性甲状腺癌!, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=106.37.162.**, createdTime=Wed Feb 25 17:08:00 CST 2015, time=2015-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16920, encodeId=9f6b1692007, content=不错啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3yz0JbjHQ7nicJU7lHMOu0Itf3Zv3VBzEvK3k4AFPBXhiaxIRNGVI33GicoRXQEjkaasjdlWKwZuwcyhDP9Jibqt5ct/0, createdBy=f1281613275, createdName=zhouanxiu, createdTime=Tue Feb 24 15:19:00 CST 2015, time=2015-02-24, status=1, ipAttribution=)]
    2016-01-27 doctording1

    不错,赞一个

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=146788, encodeId=223e146e8852, content=直到身边亲人被过度了才体验深刻,病人观念也没跟上,医生也很少考虑全切后的终生治疗及并发症各种的麻烦, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRtNT7AWKboIfjpeY6Nw6lNxAc4w1aibutHSqCJ2c3AbwfqpRia4IrnzU2mK3Ojx2Har8AUUyhC0kl7/0, createdBy=ecc31722157, createdName=1decafd9m46(暂无匿称), createdTime=Wed Oct 12 13:29:18 CST 2016, time=2016-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60775, encodeId=1e4460e750c, content=不错,赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:53:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60776, encodeId=8b1d60e765c, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:53:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60777, encodeId=dbeb60e7776, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:53:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60778, encodeId=a4de60e78d7, content=值得进一步关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:53:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24350, encodeId=75d42435071, content=1,原文出处?还是小编自己从这几个地方总结而来?2,纳入74例,样本量较少。关键是随访时间较短,对于微小癌就更短。。因为其本身发展缓慢。。。后续仍需长期进行随访。3,如前面同仁所说,关键还是能找出预测该瘤子侵袭性的因素,这将很有意义!, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160515/IMG57380B859AD1F1019.jpg, createdBy=2c5c1621956, createdName=jasonuclear, createdTime=Thu May 21 10:03:00 CST 2015, time=2015-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23705, encodeId=4a8323e0553, content=很不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sat May 16 19:31:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17618, encodeId=fc3f1e61814, content=看着比较靠谱, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ecc41613739, createdName=momoqiantan, createdTime=Thu Mar 05 10:21:00 CST 2015, time=2015-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16995, encodeId=5a5f16995dc, content=解决这个问题的前提是如何鉴别侵袭性甲状腺癌!, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=106.37.162.**, createdTime=Wed Feb 25 17:08:00 CST 2015, time=2015-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16920, encodeId=9f6b1692007, content=不错啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3yz0JbjHQ7nicJU7lHMOu0Itf3Zv3VBzEvK3k4AFPBXhiaxIRNGVI33GicoRXQEjkaasjdlWKwZuwcyhDP9Jibqt5ct/0, createdBy=f1281613275, createdName=zhouanxiu, createdTime=Tue Feb 24 15:19:00 CST 2015, time=2015-02-24, status=1, ipAttribution=)]
    2016-01-27 doctording1

    这篇文章有一定深度

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=146788, encodeId=223e146e8852, content=直到身边亲人被过度了才体验深刻,病人观念也没跟上,医生也很少考虑全切后的终生治疗及并发症各种的麻烦, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRtNT7AWKboIfjpeY6Nw6lNxAc4w1aibutHSqCJ2c3AbwfqpRia4IrnzU2mK3Ojx2Har8AUUyhC0kl7/0, createdBy=ecc31722157, createdName=1decafd9m46(暂无匿称), createdTime=Wed Oct 12 13:29:18 CST 2016, time=2016-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60775, encodeId=1e4460e750c, content=不错,赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:53:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60776, encodeId=8b1d60e765c, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:53:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60777, encodeId=dbeb60e7776, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:53:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60778, encodeId=a4de60e78d7, content=值得进一步关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:53:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24350, encodeId=75d42435071, content=1,原文出处?还是小编自己从这几个地方总结而来?2,纳入74例,样本量较少。关键是随访时间较短,对于微小癌就更短。。因为其本身发展缓慢。。。后续仍需长期进行随访。3,如前面同仁所说,关键还是能找出预测该瘤子侵袭性的因素,这将很有意义!, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160515/IMG57380B859AD1F1019.jpg, createdBy=2c5c1621956, createdName=jasonuclear, createdTime=Thu May 21 10:03:00 CST 2015, time=2015-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23705, encodeId=4a8323e0553, content=很不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sat May 16 19:31:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17618, encodeId=fc3f1e61814, content=看着比较靠谱, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ecc41613739, createdName=momoqiantan, createdTime=Thu Mar 05 10:21:00 CST 2015, time=2015-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16995, encodeId=5a5f16995dc, content=解决这个问题的前提是如何鉴别侵袭性甲状腺癌!, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=106.37.162.**, createdTime=Wed Feb 25 17:08:00 CST 2015, time=2015-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16920, encodeId=9f6b1692007, content=不错啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3yz0JbjHQ7nicJU7lHMOu0Itf3Zv3VBzEvK3k4AFPBXhiaxIRNGVI33GicoRXQEjkaasjdlWKwZuwcyhDP9Jibqt5ct/0, createdBy=f1281613275, createdName=zhouanxiu, createdTime=Tue Feb 24 15:19:00 CST 2015, time=2015-02-24, status=1, ipAttribution=)]
    2016-01-27 doctording1

    是一篇不错的文章

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=146788, encodeId=223e146e8852, content=直到身边亲人被过度了才体验深刻,病人观念也没跟上,医生也很少考虑全切后的终生治疗及并发症各种的麻烦, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRtNT7AWKboIfjpeY6Nw6lNxAc4w1aibutHSqCJ2c3AbwfqpRia4IrnzU2mK3Ojx2Har8AUUyhC0kl7/0, createdBy=ecc31722157, createdName=1decafd9m46(暂无匿称), createdTime=Wed Oct 12 13:29:18 CST 2016, time=2016-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60775, encodeId=1e4460e750c, content=不错,赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:53:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60776, encodeId=8b1d60e765c, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:53:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60777, encodeId=dbeb60e7776, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:53:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60778, encodeId=a4de60e78d7, content=值得进一步关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:53:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24350, encodeId=75d42435071, content=1,原文出处?还是小编自己从这几个地方总结而来?2,纳入74例,样本量较少。关键是随访时间较短,对于微小癌就更短。。因为其本身发展缓慢。。。后续仍需长期进行随访。3,如前面同仁所说,关键还是能找出预测该瘤子侵袭性的因素,这将很有意义!, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160515/IMG57380B859AD1F1019.jpg, createdBy=2c5c1621956, createdName=jasonuclear, createdTime=Thu May 21 10:03:00 CST 2015, time=2015-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23705, encodeId=4a8323e0553, content=很不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sat May 16 19:31:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17618, encodeId=fc3f1e61814, content=看着比较靠谱, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ecc41613739, createdName=momoqiantan, createdTime=Thu Mar 05 10:21:00 CST 2015, time=2015-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16995, encodeId=5a5f16995dc, content=解决这个问题的前提是如何鉴别侵袭性甲状腺癌!, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=106.37.162.**, createdTime=Wed Feb 25 17:08:00 CST 2015, time=2015-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16920, encodeId=9f6b1692007, content=不错啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3yz0JbjHQ7nicJU7lHMOu0Itf3Zv3VBzEvK3k4AFPBXhiaxIRNGVI33GicoRXQEjkaasjdlWKwZuwcyhDP9Jibqt5ct/0, createdBy=f1281613275, createdName=zhouanxiu, createdTime=Tue Feb 24 15:19:00 CST 2015, time=2015-02-24, status=1, ipAttribution=)]
    2016-01-27 doctording1

    值得进一步关注

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=146788, encodeId=223e146e8852, content=直到身边亲人被过度了才体验深刻,病人观念也没跟上,医生也很少考虑全切后的终生治疗及并发症各种的麻烦, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRtNT7AWKboIfjpeY6Nw6lNxAc4w1aibutHSqCJ2c3AbwfqpRia4IrnzU2mK3Ojx2Har8AUUyhC0kl7/0, createdBy=ecc31722157, createdName=1decafd9m46(暂无匿称), createdTime=Wed Oct 12 13:29:18 CST 2016, time=2016-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60775, encodeId=1e4460e750c, content=不错,赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:53:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60776, encodeId=8b1d60e765c, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:53:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60777, encodeId=dbeb60e7776, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:53:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60778, encodeId=a4de60e78d7, content=值得进一步关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:53:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24350, encodeId=75d42435071, content=1,原文出处?还是小编自己从这几个地方总结而来?2,纳入74例,样本量较少。关键是随访时间较短,对于微小癌就更短。。因为其本身发展缓慢。。。后续仍需长期进行随访。3,如前面同仁所说,关键还是能找出预测该瘤子侵袭性的因素,这将很有意义!, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160515/IMG57380B859AD1F1019.jpg, createdBy=2c5c1621956, createdName=jasonuclear, createdTime=Thu May 21 10:03:00 CST 2015, time=2015-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23705, encodeId=4a8323e0553, content=很不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sat May 16 19:31:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17618, encodeId=fc3f1e61814, content=看着比较靠谱, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ecc41613739, createdName=momoqiantan, createdTime=Thu Mar 05 10:21:00 CST 2015, time=2015-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16995, encodeId=5a5f16995dc, content=解决这个问题的前提是如何鉴别侵袭性甲状腺癌!, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=106.37.162.**, createdTime=Wed Feb 25 17:08:00 CST 2015, time=2015-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16920, encodeId=9f6b1692007, content=不错啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3yz0JbjHQ7nicJU7lHMOu0Itf3Zv3VBzEvK3k4AFPBXhiaxIRNGVI33GicoRXQEjkaasjdlWKwZuwcyhDP9Jibqt5ct/0, createdBy=f1281613275, createdName=zhouanxiu, createdTime=Tue Feb 24 15:19:00 CST 2015, time=2015-02-24, status=1, ipAttribution=)]
    2015-05-21 jasonuclear

    1,原文出处?还是小编自己从这几个地方总结而来?2,纳入74例,样本量较少。关键是随访时间较短,对于微小癌就更短。。因为其本身发展缓慢。。。后续仍需长期进行随访。3,如前面同仁所说,关键还是能找出预测该瘤子侵袭性的因素,这将很有意义!

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=146788, encodeId=223e146e8852, content=直到身边亲人被过度了才体验深刻,病人观念也没跟上,医生也很少考虑全切后的终生治疗及并发症各种的麻烦, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRtNT7AWKboIfjpeY6Nw6lNxAc4w1aibutHSqCJ2c3AbwfqpRia4IrnzU2mK3Ojx2Har8AUUyhC0kl7/0, createdBy=ecc31722157, createdName=1decafd9m46(暂无匿称), createdTime=Wed Oct 12 13:29:18 CST 2016, time=2016-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60775, encodeId=1e4460e750c, content=不错,赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:53:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60776, encodeId=8b1d60e765c, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:53:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60777, encodeId=dbeb60e7776, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:53:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60778, encodeId=a4de60e78d7, content=值得进一步关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:53:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24350, encodeId=75d42435071, content=1,原文出处?还是小编自己从这几个地方总结而来?2,纳入74例,样本量较少。关键是随访时间较短,对于微小癌就更短。。因为其本身发展缓慢。。。后续仍需长期进行随访。3,如前面同仁所说,关键还是能找出预测该瘤子侵袭性的因素,这将很有意义!, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160515/IMG57380B859AD1F1019.jpg, createdBy=2c5c1621956, createdName=jasonuclear, createdTime=Thu May 21 10:03:00 CST 2015, time=2015-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23705, encodeId=4a8323e0553, content=很不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sat May 16 19:31:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17618, encodeId=fc3f1e61814, content=看着比较靠谱, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ecc41613739, createdName=momoqiantan, createdTime=Thu Mar 05 10:21:00 CST 2015, time=2015-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16995, encodeId=5a5f16995dc, content=解决这个问题的前提是如何鉴别侵袭性甲状腺癌!, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=106.37.162.**, createdTime=Wed Feb 25 17:08:00 CST 2015, time=2015-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16920, encodeId=9f6b1692007, content=不错啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3yz0JbjHQ7nicJU7lHMOu0Itf3Zv3VBzEvK3k4AFPBXhiaxIRNGVI33GicoRXQEjkaasjdlWKwZuwcyhDP9Jibqt5ct/0, createdBy=f1281613275, createdName=zhouanxiu, createdTime=Tue Feb 24 15:19:00 CST 2015, time=2015-02-24, status=1, ipAttribution=)]
    2015-05-16 ljjj1053

    很不错学习了

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=146788, encodeId=223e146e8852, content=直到身边亲人被过度了才体验深刻,病人观念也没跟上,医生也很少考虑全切后的终生治疗及并发症各种的麻烦, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRtNT7AWKboIfjpeY6Nw6lNxAc4w1aibutHSqCJ2c3AbwfqpRia4IrnzU2mK3Ojx2Har8AUUyhC0kl7/0, createdBy=ecc31722157, createdName=1decafd9m46(暂无匿称), createdTime=Wed Oct 12 13:29:18 CST 2016, time=2016-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60775, encodeId=1e4460e750c, content=不错,赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:53:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60776, encodeId=8b1d60e765c, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:53:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60777, encodeId=dbeb60e7776, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:53:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60778, encodeId=a4de60e78d7, content=值得进一步关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:53:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24350, encodeId=75d42435071, content=1,原文出处?还是小编自己从这几个地方总结而来?2,纳入74例,样本量较少。关键是随访时间较短,对于微小癌就更短。。因为其本身发展缓慢。。。后续仍需长期进行随访。3,如前面同仁所说,关键还是能找出预测该瘤子侵袭性的因素,这将很有意义!, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160515/IMG57380B859AD1F1019.jpg, createdBy=2c5c1621956, createdName=jasonuclear, createdTime=Thu May 21 10:03:00 CST 2015, time=2015-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23705, encodeId=4a8323e0553, content=很不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sat May 16 19:31:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17618, encodeId=fc3f1e61814, content=看着比较靠谱, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ecc41613739, createdName=momoqiantan, createdTime=Thu Mar 05 10:21:00 CST 2015, time=2015-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16995, encodeId=5a5f16995dc, content=解决这个问题的前提是如何鉴别侵袭性甲状腺癌!, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=106.37.162.**, createdTime=Wed Feb 25 17:08:00 CST 2015, time=2015-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16920, encodeId=9f6b1692007, content=不错啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3yz0JbjHQ7nicJU7lHMOu0Itf3Zv3VBzEvK3k4AFPBXhiaxIRNGVI33GicoRXQEjkaasjdlWKwZuwcyhDP9Jibqt5ct/0, createdBy=f1281613275, createdName=zhouanxiu, createdTime=Tue Feb 24 15:19:00 CST 2015, time=2015-02-24, status=1, ipAttribution=)]
    2015-03-05 momoqiantan

    看着比较靠谱

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=146788, encodeId=223e146e8852, content=直到身边亲人被过度了才体验深刻,病人观念也没跟上,医生也很少考虑全切后的终生治疗及并发症各种的麻烦, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRtNT7AWKboIfjpeY6Nw6lNxAc4w1aibutHSqCJ2c3AbwfqpRia4IrnzU2mK3Ojx2Har8AUUyhC0kl7/0, createdBy=ecc31722157, createdName=1decafd9m46(暂无匿称), createdTime=Wed Oct 12 13:29:18 CST 2016, time=2016-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60775, encodeId=1e4460e750c, content=不错,赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:53:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60776, encodeId=8b1d60e765c, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:53:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60777, encodeId=dbeb60e7776, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:53:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60778, encodeId=a4de60e78d7, content=值得进一步关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:53:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24350, encodeId=75d42435071, content=1,原文出处?还是小编自己从这几个地方总结而来?2,纳入74例,样本量较少。关键是随访时间较短,对于微小癌就更短。。因为其本身发展缓慢。。。后续仍需长期进行随访。3,如前面同仁所说,关键还是能找出预测该瘤子侵袭性的因素,这将很有意义!, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160515/IMG57380B859AD1F1019.jpg, createdBy=2c5c1621956, createdName=jasonuclear, createdTime=Thu May 21 10:03:00 CST 2015, time=2015-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23705, encodeId=4a8323e0553, content=很不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sat May 16 19:31:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17618, encodeId=fc3f1e61814, content=看着比较靠谱, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ecc41613739, createdName=momoqiantan, createdTime=Thu Mar 05 10:21:00 CST 2015, time=2015-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16995, encodeId=5a5f16995dc, content=解决这个问题的前提是如何鉴别侵袭性甲状腺癌!, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=106.37.162.**, createdTime=Wed Feb 25 17:08:00 CST 2015, time=2015-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16920, encodeId=9f6b1692007, content=不错啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3yz0JbjHQ7nicJU7lHMOu0Itf3Zv3VBzEvK3k4AFPBXhiaxIRNGVI33GicoRXQEjkaasjdlWKwZuwcyhDP9Jibqt5ct/0, createdBy=f1281613275, createdName=zhouanxiu, createdTime=Tue Feb 24 15:19:00 CST 2015, time=2015-02-24, status=1, ipAttribution=)]
    2015-02-25 106.37.162.**

    解决这个问题的前提是如何鉴别侵袭性甲状腺癌!

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=146788, encodeId=223e146e8852, content=直到身边亲人被过度了才体验深刻,病人观念也没跟上,医生也很少考虑全切后的终生治疗及并发症各种的麻烦, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRtNT7AWKboIfjpeY6Nw6lNxAc4w1aibutHSqCJ2c3AbwfqpRia4IrnzU2mK3Ojx2Har8AUUyhC0kl7/0, createdBy=ecc31722157, createdName=1decafd9m46(暂无匿称), createdTime=Wed Oct 12 13:29:18 CST 2016, time=2016-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60775, encodeId=1e4460e750c, content=不错,赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:53:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60776, encodeId=8b1d60e765c, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:53:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60777, encodeId=dbeb60e7776, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:53:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60778, encodeId=a4de60e78d7, content=值得进一步关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:53:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24350, encodeId=75d42435071, content=1,原文出处?还是小编自己从这几个地方总结而来?2,纳入74例,样本量较少。关键是随访时间较短,对于微小癌就更短。。因为其本身发展缓慢。。。后续仍需长期进行随访。3,如前面同仁所说,关键还是能找出预测该瘤子侵袭性的因素,这将很有意义!, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160515/IMG57380B859AD1F1019.jpg, createdBy=2c5c1621956, createdName=jasonuclear, createdTime=Thu May 21 10:03:00 CST 2015, time=2015-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23705, encodeId=4a8323e0553, content=很不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sat May 16 19:31:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17618, encodeId=fc3f1e61814, content=看着比较靠谱, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ecc41613739, createdName=momoqiantan, createdTime=Thu Mar 05 10:21:00 CST 2015, time=2015-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16995, encodeId=5a5f16995dc, content=解决这个问题的前提是如何鉴别侵袭性甲状腺癌!, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=106.37.162.**, createdTime=Wed Feb 25 17:08:00 CST 2015, time=2015-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16920, encodeId=9f6b1692007, content=不错啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3yz0JbjHQ7nicJU7lHMOu0Itf3Zv3VBzEvK3k4AFPBXhiaxIRNGVI33GicoRXQEjkaasjdlWKwZuwcyhDP9Jibqt5ct/0, createdBy=f1281613275, createdName=zhouanxiu, createdTime=Tue Feb 24 15:19:00 CST 2015, time=2015-02-24, status=1, ipAttribution=)]
    2015-02-24 zhouanxiu

    不错啊

    0

相关资讯

荆志成:肺栓塞管理策略新进展,解读《急性肺栓塞诊断及管理指南》

近年来,急性肺栓塞领域有关新药物、新治疗、新研究、新探索的证据不断积累,结合临床实际需求,欧洲心脏病学会(ESC)在2014年ESC年会上发布新版《急性肺栓塞诊断及管理指南》(以下简称“新指南”)。新指南在充分考虑诊断和治疗的风险/获益比以及对预后影响的基础上,针对不同的患者推荐最佳管理策略。与2008年版指南相比,新指南在风险评估分层、新型口服抗凝药的使用、特殊问题的处理等方面有较多更新

BMJ综述:如何诊断纤维肌痛?

大多人认为,纤维肌痛的诊断在临床上并没有特别的帮助。但依据作者的经验,很多患者在医生清楚详细的解释纤维肌痛症后可获得一定精神方面的缓解,诊断纤维肌痛的患者确保他们除外了肿瘤或其他疾病的诊断,对他们的精神方面是个缓解。研究报道显示,诊断纤维肌痛的患者在诊断疾病后就诊的次数和医疗花费显著减少。 目前并没有特别的血液或影像学方法诊断纤维肌痛,C反应蛋白浓度和ESR在这类患者中通常并不升高。纤维肌痛的诊

Neurology:PARK10进一步被证实是散发性帕金森病的主要基因位点

有关帕金森病(PD)遗传学研究,其病理学诊断存在的差异较大。为了将差异最小化,活检-诊断帕金森病遗传学联合会针对神经病理诊断的PD病人及对照人群进行了全基因关联研究。研究方法:对符合神经病理学诊断标准的484例病例和1145例对照进行了基因分型,然后对大约3922209个位点进行全基因关联研究。研究结果:1号染色体上一小区域和PD有强相关性(rs10788972; p = 6.2 × 10−8)。

各科诊断公式大全(医学知识,可收藏)

呼吸系统疾病诊断公式  1.急性上呼吸道感染=咽痛+咳嗽+发热  2.肺炎  (1)大叶性肺炎=成人+受凉+高热+咳铁锈色痰  (2)克雷伯杆菌肺炎=咳砖红色痰+X线片空洞  (3)支原体肺炎=儿童+刺激性干咳+关节疼+抗生素无效  (4)支气管肺炎=婴幼儿+发热+呼吸困难症状(鼻翼扇动、三凹征阳性)  (5)金色葡萄球菌肺炎=高热+胸痛+脓血痰+X线片状影  3.结核病  (1)肺结核=青壮年+

过度医疗苦果:韩国甲状腺癌早期诊断热

1、医学进步竟可以造成流行病? 流行病专家还有另外一项任务:识别和控制医疗界造成的流行病。韩国在过去20年里,这里甲状腺癌的发病率提高到了最初的15倍。全世界任何地方都没有哪种癌症能如此之快地增长。 我们受过的教育都是,为发病率的显著提高寻找生物学上的解释,或许是新的病原体,或许是环境暴露。然而在韩国,我们看到了不同的情况,这种流行病是因为诊断造成的。 2、韩国如何把甲状腺癌从罕见病变成常见